https://www.barrons.com/articles/gilead-shares-sink-on-disappointing-earnings-51596143675 Gilead Sciences reported second-quarter earnings on Thursday afternoon that missed Wall Street expectations, sending the stock down 2.5% in after-hours trading.“We are already starting to see early signs of recovery from this impact and we are fully confident in our long-term HIV leadership.” Write to Josh Nathan-Kazis at josh.nathan-kazis@barrons.com Gilead Sciences reported second-quarter earnings on Thursday afternoon that missed Wall Street expectations, sending the stock down 2.